Jim Cramer breaks down shares of Estee Lauder, Clorox, Eli Lilly and more
‘Mad Money’ host Jim Cramer and the ‘Squawk on the Street’ team discuss shares of Estee Lauder, Chegg, Clorox, HCA Holdings and more following the opening bell on Tuesday.
Read More »
Schwab’s Omar Aguilar expects more pain in equity markets due to economic deceleration and earnings
Jonathan Golub, Credit Suisse chief U.S. equity strategist, and Omar Aguilar, Schwab Asset Management CEO and CIO, join ‘Squawk on the Street’ to discuss opportunities in equity markets, whether the stock market has hit its bottom and more.
Read More »
Elon Musk in talks for new Twitter financing, report says
According to Reuters, Elon Musk is in talks with large investment firms and high net-worth individuals about taking on more financing for his takeover of social media giant Twitter.
Read More »
Jim Cramer defends Fed Chair Powell’s efforts against inflation: ‘He may figure this out’
‘Mad Money’ host Jim Cramer and the ‘Squawk on the Street’ team react to comments from legendary investor Paul Tudor Jones over Federal Reserve Chair Jerome Powell and the concerning U.S. economic outlook.
Read More »
I’m concerned about recession, but there is reason to be long-term optimistic, says Glenn Hutchins
Veteran investor Glenn Hutchins, chairman of North Island and director at AT&T, joins CNBC’s ‘Squawk Box’ to provide a market outlook ahead of the Federal Reserve’s interest rate decision later this week.
Read More »
LIVE: NASA Administrator Bill Nelson testifies before Congress on 2023 budget request — 5/3/22
The Senate Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies holds a hearing to examine proposed budget estimates and justification for fiscal year 2023 for the National Aeronautics and Space Administration and the National Science Foundation. Witnesses include Bill…
Read More »
Former Dallas Fed president on upcoming interest rate decision: I do not expect any surprises
Former Dallas Fed President Richard Fisher, senior advisor to Barclays, joins CNBC’s ‘Squawk Box’ ahead of the Federal Reserve’s Federal Open Market Committee meeting this week to discuss inflation, interest rates and more.
Read More »
Biogen CEO Michel Vounatsos to step down following troubled Alzheimer’s drug launch
CNBC’s Meg Tirrell joins ‘Squawk Box’ to report that Biogen CEO Michel Vounatsos will step down amid the company’s troubled launch of its historic Alzheimer’s drug Aduhelm.
Read More »